Your browser doesn't support javascript.
loading
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap.
Daneshnia, Farnaz; de Almeida Júnior, João N; Ilkit, Macit; Lombardi, Lisa; Perry, Austin M; Gao, Marilyn; Nobile, Clarissa J; Egger, Matthias; Perlin, David S; Zhai, Bing; Hohl, Tobias M; Gabaldón, Toni; Colombo, Arnaldo Lopes; Hoenigl, Martin; Arastehfar, Amir.
Afiliação
  • Daneshnia F; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Institute of Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, Netherlands.
  • de Almeida Júnior JN; Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil; Clinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Ilkit M; Division of Mycology, Faculty of Medicine, University of Çukurova, Adana, Türkiye.
  • Lombardi L; School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
  • Perry AM; Department of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, CA, USA; Quantitative and Systems Biology Graduate Program, University of California Merced, Merced, CA, USA.
  • Gao M; Department of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, CA, USA.
  • Nobile CJ; Department of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, CA, USA; Health Sciences Research Institute, University of California Merced, Merced, CA, USA.
  • Egger M; Division of Infectious Diseases, ECMM Excellence Center, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Perlin DS; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA; Department of Medical Sciences, Hackensack School of Medicine, Nutley, NJ, USA; Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Zhai B; CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Hohl TM; Infectious Disease Service, Department of Medicine and Human Oncology, and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Gabaldón T; Life Sciences Programme, Supercomputing Center, Barcelona, Spain; Institute for Research in Biomedicine, Barcelona, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain.
  • Colombo AL; Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Hoenigl M; Division of Infectious Diseases, ECMM Excellence Center, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Bio TechMed, Graz, Austria; Translational Medical Mycology Research Group, Medical University of Graz, Graz, Austria. Electronic address: hoeniglmartin@gmail.com.
  • Arastehfar A; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: aarastehfar@mgh.harvard.edu.
Lancet Microbe ; 4(6): e470-e480, 2023 06.
Article em En | MEDLINE | ID: mdl-37121240

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluconazol / Candidemia Limite: Adult / Humans / Newborn Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluconazol / Candidemia Limite: Adult / Humans / Newborn Idioma: En Ano de publicação: 2023 Tipo de documento: Article